In inflammation-associated cancers (Table 2), CHI3L1 expression in tumor tissues is consistently associated with increased tumor aggressiveness, higher histological grade, advanced clinical stage, and poorer prognosis [94,97,101,104,105,106,109,114,115]. This evidence concerns the gene CHI3L1 and cancer.